Cargando…

Editorial: Targeting Phosphorylation and Glycosylation of Membrane-Bound Oncogenic Drivers, Receptors and Adhesion Molecules to Control Constitutive Proliferation of Human Carcinoma Cells

Detalles Bibliográficos
Autores principales:	Hussain, Muhammad R. M., Hoessli, Daniel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079273/ https://www.ncbi.nlm.nih.gov/pubmed/30109212 http://dx.doi.org/10.3389/fonc.2018.00283

Ejemplares similares

Charge and Polarity Preferences for N-Glycosylation: A Genome-Wide In Silico Study and Its Implications Regarding Constitutive Proliferation and Adhesion of Carcinoma Cells
por: Manwar Hussain, Muhammad Ramzan, et al.
Publicado: (2018)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation
por: Ahmad, Ishtiaq, et al.
Publicado: (2006)

Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules
Publicado: (1989)

Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
por: Zhang, Runjiao, et al.
Publicado: (2021)

Editorial: Glycosylation Changes in Cancer: An Innovative Frontier at the Interface of Cancer and Glycobiology
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2016)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
por: Konstantinidou, Georgia, et al.
Publicado: (2020)

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer
por: Zhao, Yiming, et al.
Publicado: (2021)

The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation
por: Cui, Jinfeng, et al.
Publicado: (2022)

Detection and Characterization of Phosphorylation, Glycosylation, and Fatty Acid Bound to Fetuin A in Human Blood
por: Kovářová, Markéta, et al.
Publicado: (2021)

Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia
por: Windisch, Roland, et al.
Publicado: (2019)

Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells
por: Hilgers, Katharina, et al.
Publicado: (2022)

Editorial: Metastasis: From Cell Adhesion and Beyond
por: Gkretsi, Vasiliki, et al.
Publicado: (2019)

A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib
por: Chen, Dong, et al.
Publicado: (2020)

N-glycosylation controls the function of junctional adhesion molecule-A
por: Scott, David W., et al.
Publicado: (2015)

Mathematical Modeling of Cancer Invasion: The Role of Membrane-Bound Matrix Metalloproteinases
por: Deakin, Niall E., et al.
Publicado: (2013)

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma
por: Xu, Jian-Zhao, et al.
Publicado: (2021)

Reduction of Endothelial Nitric Oxide Increases the Adhesiveness of Constitutive Endothelial Membrane ICAM-1 through Src-Mediated Phosphorylation
por: Gao, Feng, et al.
Publicado: (2018)

Editorial: Molecules of the extracellular matrix as cancer targets
por: Karamanos, Nikos K., et al.
Publicado: (2022)

Cell Adhesion Molecules in Neuroblastoma: Complex Roles, Therapeutic Potential
por: Heinly, Briana E., et al.
Publicado: (2022)

The Oncogenic Effects, Pathways, and Target Molecules of JC Polyoma Virus T Antigen in Cancer Cells
por: Zheng, Hua-Chuan, et al.
Publicado: (2022)

Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
por: Parisi, Eva, et al.
Publicado: (2022)

The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer
por: Hu, Qing, et al.
Publicado: (2022)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients
por: Li, Wen, et al.
Publicado: (2022)

Glycosylated Notch and Cancer
por: Pakkiriswami, Shanmugasundaram, et al.
Publicado: (2016)

Editorial: Adhesion molecules and autoimmune diseases
por: Fan, Zhichao, et al.
Publicado: (2022)

Phosphorylation of membrane-bound guanylate cyclase of sea urchin spermatozoa
Publicado: (1986)

Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer
por: Mukhopadhyay, Alka, et al.
Publicado: (2013)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

Editorial: Role of membrane-bound and circulating endoglin in disease
por: Bernabeu, Carmelo, et al.
Publicado: (2023)

Editorial: Molecules Balancing Immunological Surveillance against Cancer and Autoimmune Diseases
por: Sharabi, Amir
Publicado: (2016)

Constitutive androstane receptor 1 is constitutively bound to chromatin and ‘primed’ for transactivation in hepatocytes
por: McMahon, Michael, et al.
Publicado: (2019)

Glycosylation Changes in Prostate Cancer Progression
por: Butler, William, et al.
Publicado: (2021)

Editorial: Overcoming the cell membrane to target intracellular oncoproteins
por: Brown, Christopher J., et al.
Publicado: (2023)

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
por: Malapelle, Umberto, et al.
Publicado: (2023)

Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis
por: Ding, Peiwen, et al.
Publicado: (2023)

Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
por: Qiu, Luping, et al.
Publicado: (2018)

Altered Tumor-Cell Glycosylation Promotes Metastasis
por: Häuselmann, Irina, et al.
Publicado: (2014)

Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery
por: Torres-Pérez, Sergio Andrés, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cm6eom4kislvdmkfkttkismq4k